SATB2-Associated Syndrome Due to a c.715C>T:p(Arg239*) Variant in Adulthood: Natural History and Literature Review

被引:1
作者
Copelli, Matheus de Mello [1 ]
Pairet, Eleonore [2 ]
Atique-Tacla, Milena [1 ]
Vieira, Tarsis Paiva [1 ]
Appenzeller, Simone [3 ]
Helaers, Raphael [2 ]
Vikkula, Miikka [2 ]
Gil-da-Silva-Lopes, Vera Lucia [1 ]
机构
[1] Univ Campinas UNICAMP, Dept Translat Med, Area Med Genet & Genom Med, BR-13083887 Campinas, SP, Brazil
[2] Catholic Univ Louvain, Duve Inst, Human Mol Genet, B-1200 Brussels, Belgium
[3] Univ Campinas UNICAMP, Sch Med Sci, Dept Orthoped Rheumatol & Traumatol, BR-13083887 Campinas, SP, Brazil
关键词
natural history; whole-exome sequencing; cleft palate; behavior problems; osteopenia; SATB2; MOLECULAR CHARACTERIZATION; BINDING PROTEIN; CLEFT-PALATE; SATB2; DELETION; MICRODELETION; DUPLICATION; DISABILITY; PATIENT; SPEECH;
D O I
10.3390/genes14040882
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
SATB2-associated syndrome (SAS) is a rare condition, and it is characterized by severe developmental delay/intellectual disability, especially severe speech delay/or absence, craniofacial abnormalities, and behavioral problems. Most of the published reports are limited to children, with little information about the natural history of the disease and the possible novel signs and symptoms or behavioral changes in adulthood. We describe the management and follow-up of a 25-year-old male with SAS due to a de novo heterozygous nonsense variant SATB2:c.715C>T:p.(Arg239*) identified by whole-exome sequencing and review the literature. The case herein described contributes to a better characterization of the natural history of this genetic condition and in addition to the genotype-phenotype correlation of the SATB2:c.715C>T:p.(Arg239*) variant in SAS, highlights some particularities of its management.
引用
收藏
页数:8
相关论文
共 29 条
  • [1] Case series: 2q33.1 microdeletion syndromed-further delineation of the phenotype
    Balasubramanian, M.
    Smith, K.
    Basel-Vanagaite, L.
    Feingold, M. F.
    Brock, P.
    Gowans, G. C.
    Vasudevan, P. C.
    Cresswell, L.
    Taylor, E. J.
    Harris, C. J.
    Friedman, N.
    Moran, R.
    Feret, H.
    Zackai, E. H.
    Theisen, A.
    Rosenfeld, J. A.
    Parker, M. J.
    [J]. JOURNAL OF MEDICAL GENETICS, 2011, 48 (05) : 290 - 298
  • [2] Clinical and molecular consequences of disease-associated de novo mutations in SATB2
    Bengani, Hemant
    Handley, Mark
    Alvi, Mohsan
    Ibitoye, Rita
    Lees, Melissa
    Lynch, Sally Ann
    Lam, Wayne
    Fannemel, Madeleine
    Nordgren, Ann
    Malmgren, H.
    Kvarnung, M.
    Mehta, Sarju
    McKee, Shane
    Whiteford, Margo
    Stewart, Fiona
    Connell, Fiona
    Clayton-Smith, Jill
    Mansour, Sahar
    Mohammed, Shehla
    Fryer, Alan
    Morton, Jenny
    Grozeva, Detelina
    Asam, Tara
    Moore, David
    Sifrim, Alejandro
    McRae, Jeremy
    Hurles, Matthew E.
    Firth, Helen V.
    Raymond, F. Lucy
    Kini, Usha
    Nellaker, Christoffer
    FitzPatrick, David R.
    [J]. GENETICS IN MEDICINE, 2017, 19 (08) : 900 - 908
  • [3] Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development
    Britanova, Olga
    Depew, Michael J.
    Schwark, Manuela
    Thomas, Bethan L.
    Miletich, Isabelle
    Sharpe, Paul
    Tarabykin, Victor
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (04) : 668 - 678
  • [4] The Refinement of the Critical Region for the 2q31.2q32.3 Deletion Syndrome Indicates Candidate Genes for Mental Retardation and Speech Impairment
    Cocchella, Alessandro
    Malacarne, Michela
    Forzano, Francesca
    Marciano, Carmela
    Pierluigi, Mauro
    Perroni, Lucia
    Faravelli, Francesca
    Di Maria, Emilio
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B (07) : 1342 - 1346
  • [5] Another patient with a de novo deletion further delineates the 2q33.1 microdeletion syndrome
    de Ravel, Thomy J.
    Balikova, Irina
    Thiry, Paul
    Vermeesch, Joris R.
    Frijns, Jean-Pierre
    [J]. EUROPEAN JOURNAL OF MEDICAL GENETICS, 2009, 52 (2-3) : 120 - 122
  • [6] SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin 11 3048 gene expression
    Dobreva, G
    Dambacher, J
    Grosschedl, R
    [J]. GENES & DEVELOPMENT, 2003, 17 (24) : 3048 - 3061
  • [7] SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation
    Dobreva, Gergana
    Chahrour, Maria
    Dautzenberg, Marcel
    Chirivella, Laura
    Kanzler, Benoit
    Farinas, Isabel
    Karsenty, Gerard
    Grosschedl, Rudolf
    [J]. CELL, 2006, 125 (05) : 971 - 986
  • [8] Further delineation of the SATB2 phenotype
    Doecker, Dennis
    Schubach, Max
    Menzel, Moritz
    Munz, Marita
    Spaich, Christiane
    Biskup, Saskia
    Bartholdi, Deborah
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2014, 22 (08) : 1034 - 1039
  • [9] Satb2 regulates proliferation and nuclear integrity of pre-osteoblasts
    Dowrey, Todd
    Schwager, Evelyn E.
    Duong, Julieann
    Merkuri, Fjodor
    Zarate, Yuri A.
    Fish, Jennifer L.
    [J]. BONE, 2019, 127 : 488 - 498
  • [10] Critical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region
    Ferreira, Susana Isabel
    Matoso, Eunice
    Venancio, Margarida
    Saraiva, Jorge
    Melo, Joana B.
    Carreira, Isabel Marques
    [J]. MOLECULAR CYTOGENETICS, 2012, 5